Is There Validity in Propensity Score-Matched Estimates of Adjuvant Chemotherapy Effects for Patients With Rectal Cancer?

被引：10
作者：
Chang, George J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Surg Oncol Hlth Serv Res, Houston, TX 77030 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 07期
基金：
美国国家卫生研究院;
关键词：
PHASE-III TRIAL; PRIMARY TUMOR; COLON-CANCER; FLUOROURACIL; CHEMORADIOTHERAPY; OXALIPLATIN; LEUCOVORIN;
D O I：
10.1001/jamaoncol.2018.0227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：921 / 923
页数：3
相关论文
共 16 条
  • [1] Comparative Effectiveness of Primary Tumor Resection in Patients With Stage IV Colon Cancer
    Alawadi, Zeinab
    Phatak, Uma R.
    Hu, Chung-Yuan
    Bailey, Christina E.
    You, Y. Nancy
    Kao, Lillian S.
    Massarweh, Nader N.
    Feig, Barry W.
    Rodriguez-Bigas, Miguel A.
    Skibber, John M.
    Chang, George J.
    [J]. CANCER, 2017, 123 (07) : 1124 - 1133
  • [2] No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)
    Aldo, Sainato
    Valentina, Cernusco Luna Nunzia
    Vincenzo, Valentini
    Antonino, De Paoli
    Riccardo, Maurizi Enrici
    Marco, Lupattelli
    Cynthia, Aristei
    Cristiana, Vidali
    Monica, Conti
    Alessandra, Galardi
    Pietro, Ponticelli
    Luisa, Friso Maria
    Tiziana, Iannone
    Mattia, Osti Falchetto
    Bruno, Manfredi
    Marianna, Coppola
    Cinzia, Orlandini
    Luca, Cionini
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 113 (02) : 223 - 229
  • [3] The use of the propensity score for estimating treatment effects: administrative versus clinical data
    Austin, PC
    Mamdani, MM
    Stukel, TA
    Anderson, GM
    Tu, JV
    [J]. STATISTICS IN MEDICINE, 2005, 24 (10) : 1563 - 1578
  • [4] Rectal Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines
    Benson, Al B., III
    Venook, Alan P.
    Bekaii-Saab, Tanios
    Chan, Emily
    Chen, Yi-Jen
    Cooper, Harry S.
    Engstrom, Paul F.
    Enzinger, Peter C.
    Fenton, Moon J.
    Fuchs, Charles S.
    Grem, Jean L.
    Grothey, Axel
    Hochster, Howard S.
    Hunt, Steven
    Kamel, Ahmed
    Kirilcuk, Natalie
    Leong, Lucille A.
    Lin, Edward
    Messersmith, Wells A.
    Mulcahy, Mary F.
    Murphy, James D.
    Nurkin, Steven
    Rohren, Eric
    Ryan, David P.
    Saltz, Leonard
    Sharma, Sunil
    Shibata, David
    Skibber, John M.
    Sofocleous, Constantinos T.
    Stoffel, Elena M.
    Stotsky-Himelfarb, Eden
    Willett, Christopher G.
    Gregory, Kristina M.
    Freedman-Cass, Deborah
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06): : 719 - 728
  • [5] Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data
    Booth, Christopher M.
    Karim, Safiya
    Peng, Yingwei
    Siemens, D. Robert
    Brennan, Kelly
    Mackillop, William J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 533 - +
  • [6] Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
    Breugom, A. J.
    van Gijn, W.
    Muller, E. W.
    Berglund, A.
    van den Broek, C. B. M.
    Fokstuen, T.
    Gelderblom, H.
    Kapiteijn, E.
    Leer, J. W. H.
    Marijnen, C. A. M.
    Martijn, H.
    Kranenbarg, E. Meershoek-Klein
    Nagtegaal, I. D.
    Pahlman, L.
    Punt, C. J. A.
    Putter, H.
    Roodvoets, A. G. H.
    Rutten, H. J. T.
    Steup, W. H.
    Glimelius, B.
    van de Velde, C. J. H.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (04) : 696 - 701
  • [7] Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
    Breugom, Anne J.
    Swets, Marloes
    Bosset, Jean-Francois
    Collette, Laurence
    Sainato, Aldo
    Cionini, Luca
    Glynne-Jones, Rob
    Counsell, Nicholas
    Bastiaannet, Esther
    van den Broek, Colette B. M.
    Liefers, Gerrit-Jan
    Putter, Hein
    van de Velde, Cornelis J. H.
    [J]. LANCET ONCOLOGY, 2015, 16 (02) : 200 - 207
  • [8] Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection
    Dossa, Fahima
    Acuna, Sergio A.
    Rickles, Aaron S.
    Berho, Mariana
    Wexner, Steven D.
    Quereshy, Fayez A.
    Baxter, Nancy N.
    Chadi, Sami A.
    [J]. JAMA ONCOLOGY, 2018, 4 (07) : 930 - 937
  • [9] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
    Gill, S
    Loprinzi, CL
    Sargent, DJ
    Thomé, SD
    Alberts, SR
    Haller, DG
    Benedetti, J
    Francini, G
    Shepherd, LE
    Seitz, JF
    Labianca, R
    Chen, W
    Cha, SS
    Heldebrant, MP
    Goldberg, RM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1797 - 1806
  • [10] Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control
    Glynne-Jones, R.
    Counsell, N.
    Quirke, P.
    Mortensen, N.
    Maraveyas, A.
    Meadows, H. M.
    Ledermann, J.
    Sebag-Montefiore, D.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (07) : 1356 - 1362
12